OPNT   $20.65  -0.67% Market Closed

Opiant Pharmaceuticals Inc
Total Cash 35.38M
totalCashPerShare 6.845
EBITDA -31.47M
Total Debt 16.51M
quickRatio 5.031
currentRatio 5.475
Total Revenue 22.34M
debtToEquity 80.546
Revenue/Share 4.469
ROA -0.35506
ROE -1.05871
grossProfits 21.89M
freeCashflow -2.86M
operatingCashflow -15.47M
earningsGrowth
revenueGrowth -0.989
grossMargins -0.31847
ebitdaMargins -1.4085801
operatingMargins -1.41054
profitMargins -1.48125
enterpriseValue 87.85M
forwardPE -4.8817964
floatShares 4.38M
sharesOutstanding 5.27M
sharesShort 40.87K
sharesShortPriorMonth 27.81K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.42%
Short Ratio help_outline 0.56%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 3.969
Price To Book help_outline 5.20
earningsQuarterlyGrowth
netIncomeToCommon -33.09M
trailingEps -6.53%
forwardEps -4.23%
enterpriseToEbitda -2.79
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.21 4Q 2022
institutionsCount 46
lastUpdated April 22, 2023, 11:25 a.m.